Hosted on MSN

US has the first gene therapy drug for hearing loss. India racing to catch up

New Delhi: In a medical breakthrough, a US-based pharmaceutical company, Regeneron, received regulatory approval on 23 April for Otarmeni, the world’s first gene therapy for genetic hearing loss. The ...
AOL

FDA approves first gene therapy for genetic hearing loss

The Food and Drug Administration on Thursday approved Regeneron's Otarmeni, the first gene therapy for genetic hearing loss. The drugmaker said it will offer the drug for free to U.S. patients.
The New York Times

New Gene Therapy Enables Children With a Rare Form of Deafness to Hear

The treatment, the first of its kind, was approved by the Food and Drug Administration on Thursday. “Our baby was born deaf, and now he can hear,” said one parent. By Gina Kolata The Food and Drug ...
Forbes

New Gene Therapy For Rare Hearing Loss Wins FDA Approval—What To Know

Jessica Rendall is a reporter with experience covering a variety of health and wellness topics, including chronic disease, infectious disease, telemedicine, mental health and health technology. Kelly ...